Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70
(0.87%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy's Laboratories launches Fluphenazine Hydrochloride Tablets
>>
Dr. Reddy's Laboratories launches Capecitabine Tablets
>>
Dr Reddys Laboratories informs about press release
>>
Dr. Reddy's shines on launching Vigabatrin tablets in US market
>>
Dr. Reddy's launches Vigabatrin tablets in US market
>>
Infosys, Dr. Reddy's and Tata Consumer Products to see some action today
>>
Dr. Reddys Laboratories turns black in Q3 on consolidated basis
>>
Dr. Reddy's Laboratories eyes to launch Sputnik V vaccine for COVID-19 under EUA in March
>>
Dr. Reddy's Laboratories gets nod to conduct phase 3 clinical trial for Sputnik V vaccine in India
>>
Dr. Reddy’s Laboratories gets approval for phase 3 trials of Sputnik V Covid-19 vaccine
<<
<
48
49
50
...145
>
>>